Hopkinson Craig C. — SEC insider filings

SEC reporting owner CIK 1730048. 48 insider filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 48 filings on record, filed 2021-01-15 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Alkermes plc. (ALKS)EVP R&D, Chief Medical Officer46—30 legs · 755,285 sh · $24,747,859159
ALBIREO PHARMA, INC. (ALBO)Director2——2

Insider filings — Hopkinson Craig C.

FiledFormIssuerReported transactionsSource
2026-09-014Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $24.59 · Sale (S): 9,000 @ $46.99 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-08-034Alkermes plc. (ALKS)Option exercise (M): 104 @ $19.34 · Option exercise (M): 4,896 @ $24.59 · Sale (S): 9,000 @ $48.58 · Option exercise (M): 104 (derivative) @ $0 · Option exercise (M): 4,896 (derivative) @ $0EDGAR
2026-07-014Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 8,300 @ $51.46 · Sale (S): 700 @ $52.13 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-06-014Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 9,000 @ $41.67 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-05-014Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 9,000 @ $33.40 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-04-014Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 9,000 @ $35.51 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-03-044Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 9,000 @ $29.72 · Option exercise (M): 5,000 (derivative) @ $0 · Grant/award (A): 83,037 (derivative) @ $0 · Grant/award (A): 38,568 (derivative) @ $0EDGAR
2026-02-274Alkermes plc. (ALKS)Option exercise (M): 6,866 · Tax withholding (F): 3,049 @ $30.73 · Option exercise (M): 6,866 (derivative)EDGAR
2026-02-254Alkermes plc. (ALKS)Option exercise (M): 7,689 · Tax withholding (F): 3,414 @ $32.19 · Option exercise (M): 7,689 (derivative)EDGAR
2026-02-204Alkermes plc. (ALKS)Option exercise (M): 8,897 · Tax withholding (F): 3,504 @ $32.02 · Option exercise (M): 7,673 · Tax withholding (F): 3,407 @ $32 · Option exercise (M): 8,897 (derivative) · Option exercise (M): 7,673 (derivative)EDGAR
2026-02-064Alkermes plc. (ALKS)Grant/award (A): 25,352 · Tax withholding (F): 7,454 @ $33.55EDGAR
2026-02-024Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 5,000 @ $34.24 · Sale (S): 4,000 @ $33.54 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-01-084Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 5,000 @ $30.00 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-01-024Alkermes plc. (ALKS)Sale (S): 4,000 @ $28EDGAR
2025-12-054Alkermes plc. (ALKS)Option exercise (M): 3,748 @ $19.34 · Sale (S): 3,748 @ $30.00 · Option exercise (M): 3,748 (derivative) @ $0EDGAR
2025-12-014Alkermes plc. (ALKS)Sale (S): 4,000 @ $29.30EDGAR
2025-11-034Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 9,000 @ $30.38 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2025-10-154Alkermes plc. (ALKS)Option exercise (M): 5,000 @ $19.34 · Sale (S): 9,000 @ $31.53 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2025-02-284Alkermes plc. (ALKS)Option exercise (M): 6,866 · Tax withholding (F): 3,049 @ $34.80 · Option exercise (M): 6,866 (derivative)EDGAR
2025-02-254Alkermes plc. (ALKS)Option exercise (M): 12,279 · Tax withholding (F): 5,452 @ $35.32 · Option exercise (M): 7,689 · Tax withholding (F): 3,414 @ $35.32 · Option exercise (M): 12,279 (derivative) · Option exercise (M): 7,689 (derivative)EDGAR
2025-02-204Alkermes plc. (ALKS)Option exercise (M): 8,896 · Tax withholding (F): 3,950 @ $35.90 · Option exercise (M): 8,896 (derivative) · Grant/award (A): 63,991 (derivative) @ $0 · Grant/award (A): 30,692 (derivative) @ $0EDGAR
2025-02-144Alkermes plc. (ALKS)Option exercise (M): 87,566 @ $20.03 · Option exercise (M): 111,630 @ $19.34 · Sale (S): 171,813 @ $32.69 · Sale (S): 33,108 @ $33.27 · Option exercise (M): 108,833 @ $31.93 · Option exercise (M): 35,586 @ $24.59 · +6 moreEDGAR
2025-02-074Alkermes plc. (ALKS)Grant/award (A): 34,393 · Tax withholding (F): 15,083 @ $31.39EDGAR
2025-01-314Alkermes plc. (ALKS)Option exercise (M): 29,156 @ $20.03 · Option exercise (M): 26,589 @ $19.34 · Option exercise (M): 23,542 @ $24.59 · Option exercise (M): 18,345 @ $26.82 · Sale (S): 100,918 @ $32.05 · Option exercise (M): 29,156 (derivative) @ $0 · +3 moreEDGAR
2024-12-094Alkermes plc. (ALKS)Option exercise (M): 12,452 @ $20.03 · Option exercise (M): 12,090 @ $19.34 · Option exercise (M): 12,044 @ $24.59 · Option exercise (M): 12,411 @ $26.82 · Sale (S): 61,151 @ $32.07 · Option exercise (M): 12,452 (derivative) @ $0 · +3 moreEDGAR
2024-12-054Alkermes plc. (ALKS)Sale (S): 9,221 @ $31.50EDGAR
2024-12-044Alkermes plc. (ALKS)Sale (S): 14,349 @ $30.77EDGAR
2024-11-124Alkermes plc. (ALKS)Option exercise (M): 43,058 @ $20.03 · Sale (S): 58,996 @ $30.08 · Option exercise (M): 43,058 (derivative) @ $0EDGAR
2024-11-064Alkermes plc. (ALKS)Sale (S): 10,471 @ $29.53EDGAR
2024-02-274Alkermes plc. (ALKS)Option exercise (M): 7,689 · Tax withholding (F): 3,414 @ $29.57 · Option exercise (M): 7,689 (derivative) · Grant/award (A): 111,186 (derivative) @ $0 · Grant/award (A): 27,464 (derivative) @ $0EDGAR
2024-02-234Alkermes plc. (ALKS)Option exercise (M): 12,278 · Tax withholding (F): 5,452 @ $28.91 · Option exercise (M): 12,278 (derivative)EDGAR
2024-02-214Alkermes plc. (ALKS)Option exercise (M): 8,897 · Tax withholding (F): 3,951 @ $32.18 · Option exercise (M): 10,297 · Tax withholding (F): 4,572 @ $30.39 · Option exercise (M): 8,897 (derivative) · Option exercise (M): 10,297 (derivative)EDGAR
2024-02-124Alkermes plc. (ALKS)Grant/award (A): 46,658 · Tax withholding (F): 15,280 @ $26.77 · Other (J): 1,599 (derivative) @ $58.40 · Other (J): 1,089 (derivative) @ $65.94 · Other (J): 2,133 (derivative) @ $31.93 · Other (J): 3,376 (derivative) @ $20.03 · +7 moreEDGAR
2023-03-024ALBIREO PHARMA, INC. (ALBO)Disposition to issuer (D): 10,495 (derivative)EDGAR
2023-02-244Alkermes plc. (ALKS)Option exercise (M): 12,038 · Tax withholding (F): 5,345 @ $27.77 · Option exercise (M): 12,038 (derivative) · Grant/award (A): 120,615 (derivative) @ $0 · Grant/award (A): 30,154 (derivative) @ $0EDGAR
2023-02-224Alkermes plc. (ALKS)Option exercise (M): 8,722 · Tax withholding (F): 2,656 @ $28.07 · Option exercise (M): 10,095 · Tax withholding (F): 3,780 @ $28.07 · Grant/award (A): 22,195 · Tax withholding (F): 6,526 @ $28.07 · +5 moreEDGAR
2022-12-054ALBIREO PHARMA, INC. (ALBO)Grant/award (A): 10,495 @ $0EDGAR
2022-02-244Alkermes plc. (ALKS)Sale (S): 11,983 @ $24.76EDGAR
2022-02-234Alkermes plc. (ALKS)Sale (S): 2,306 @ $25.17 · Option exercise (M): 10,096 · Tax withholding (F): 2,966 @ $25.08 · Option exercise (M): 6,875 · Tax withholding (F): 2,022 @ $25.08 · Option exercise (M): 12,037 · +6 moreEDGAR
2022-02-174Alkermes plc. (ALKS)Option exercise (M): 3,375 · Tax withholding (F): 1,069 @ $26.79 · Option exercise (M): 3,375 (derivative)EDGAR
2021-09-164Alkermes plc. (ALKS)Grant/award (A): 15,143 @ $0 · Tax withholding (F): 5,647 @ $30.60EDGAR
2021-06-114Alkermes plc. (ALKS)Sale (S): 882 @ $24.60EDGAR
2021-06-084Alkermes plc. (ALKS)Option exercise (M): 1,250 · Tax withholding (F): 368 @ $23.50 · Option exercise (M): 1,250 (derivative)EDGAR
2021-04-164Alkermes plc. (ALKS)Sale (S): 28,920 @ $19.72EDGAR
2021-02-244Alkermes plc. (ALKS)Grant/award (A): 196,484 (derivative) @ $0 · Grant/award (A): 48,151 (derivative) @ $0EDGAR
2021-02-234Alkermes plc. (ALKS)Option exercise (M): 10,095 @ $0 · Tax withholding (F): 3,064 @ $19.58 · Option exercise (M): 6,875 @ $0 · Tax withholding (F): 2,022 @ $19.58 · Option exercise (M): 10,095 (derivative) @ $0 · Option exercise (M): 6,875 (derivative) @ $0EDGAR
2021-02-184Alkermes plc. (ALKS)Option exercise (M): 3,375 @ $0 · Tax withholding (F): 1,172 @ $19.79 · Option exercise (M): 3,375 (derivative) @ $0EDGAR
2021-01-154/AAlkermes plc. (ALKS)Option exercise (M): 6,875 @ $0 · Option exercise (M): 6,875 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1730048 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs